NPI: 1629447784 · LAND O LAKES, FL 34639 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 09/18/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 09/18/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,035 | $259K |
| 2019 | 11,954 | $2.26M |
| 2020 | 14,349 | $2.03M |
| 2021 | 6,232 | $621K |
| 2022 | 4,331 | $646K |
| 2023 | 185 | $47K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 13,395 | 883 | $2.28M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,866 | 511 | $1.66M |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,961 | 344 | $880K |
| J1756 | Injection, iron sucrose, 1 mg | 2,857 | 456 | $376K |
| A4657 | Syringe, with or without needle, each | 1,559 | 626 | $284K |
| 85041 | 773 | 423 | $113K | |
| 85048 | 717 | 384 | $104K | |
| 83970 | 271 | 160 | $42K | |
| 83540 | 196 | 111 | $34K | |
| 83550 | 196 | 111 | $34K | |
| 82728 | 203 | 112 | $34K | |
| 82108 | 54 | 37 | $10K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 38 | 14 | $5K |